Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Kogan Lee"'
Autor:
Randy D. Moore, Gail M. Thornton, Clifton R. Johnston, Gary Dobson, Jacqueline Flewitt, Kogan Lee
Publikováno v:
Cardiovascular Engineering. 10:128-135
Endovascular stents are commonly used to manage arterial diseases such as Aortic Abdominal Aneurysm (AAA), aortic dissection and coarctation. The radial force the stent applies to the vessel must be large enough to resist stent migration, but not so
Publikováno v:
Canadian journal of anaesthesia = Journal canadien d'anesthesie. 59(3)
Several fluids are available for volume therapy to address hypovolemia. We focus on two hydroxyethyl starches (HES) available for volume expansion in Canada, HES 130/0.4 (Voluven®) and HES 260/0.45 (Pentaspan®). Although information is available re
Autor:
Kogan Lee, Andrew M. Walker, Gary Dobson, Kristina D. Rinker, Clifton R. Johnston, Robert D. Shepherd
Publikováno v:
Volume 2: Biomedical and Biotechnology Engineering.
The intravenous fluid of choice for acute blood volume replacement remains controversial. We focus here on the two hydroxyethyl (HES) available in Canada: HES 130/0.40 (Voluven®) and HES 260/0.45 (Pentaspan®). Although information regarding their p
Autor:
Jacqueline Flewitt, Kogan Lee, Clifton R. Johnston, Gail M. Thornton, Gary Dobson, Randy D. Moore
Publikováno v:
ASME 2008 Summer Bioengineering Conference, Parts A and B.
Endovascular stents are used to treat aneurysms, dissections and acute traumatic disruptions of the thoracic aorta. While stents are certainly a much less invasive treatment option, the behaviour of stents in the aorta is still not well understood. G
Publikováno v:
Canadian Journal of Anesthesia/Journal canadien d'anesthésie. 55:4751761-4751762
Publikováno v:
Canadian Journal of Anesthesia/Journal canadien d'anesthésie. 55:4753841-4753842
Autor:
Clifton R. Johnston, Kogan Lee, Andrew M. Walker, Kristina D. Rinker, Gary Dobson, Robert D. Shepherd
Publikováno v:
Cardiovascular Pathology. 22:e34
anchor in the retroperitoneum resulting in the absence midgraft endothelial coverage. There was no progression of mid-graft neointimal tissue hyperplasia at 6, 8, 12, and 24 weeks (54.99±52.02 μm; 45.00±58.39; 45.84±46.60; 47.36±37.08 μm, P=.77
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kogan, Lee
Publikováno v:
Magazine Antiques; Jul/Aug2012, Vol. 179 Issue 4, p106-109, 4p